chr17-28357686-C-G
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_152464.3(TMEM199):āc.16C>Gā(p.Leu6Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,612,566 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152464.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM199 | NM_152464.3 | c.16C>G | p.Leu6Val | missense_variant | 1/6 | ENST00000292114.8 | NP_689677.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM199 | ENST00000292114.8 | c.16C>G | p.Leu6Val | missense_variant | 1/6 | 1 | NM_152464.3 | ENSP00000292114 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000243 AC: 6AN: 247250Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134312
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460350Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 726494
GnomAD4 genome AF: 0.000171 AC: 26AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74374
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 10, 2023 | The c.16C>G (p.L6V) alteration is located in exon 1 (coding exon 1) of the TMEM199 gene. This alteration results from a C to G substitution at nucleotide position 16, causing the leucine (L) at amino acid position 6 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at